{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:45:37Z","timestamp":1775699137730,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jcjo.2025.09.005","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:29:37Z","timestamp":1759955377000},"page":"412-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transient vision and intraocular pressure changes following anti-vascular endothelial growth factor injection"],"prefix":"10.1016","volume":"61","author":[{"given":"Khaldon","family":"Abbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Basilious","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Sheidow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gonder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2025.09.005_bib0001","article-title":"Anti-VEGF injections: Start to finish","author":"Baue","year":"2020","journal-title":"Rev Optometry"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0002","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Ghasemi Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0003","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ophtha.2018.01.022","article-title":"Endophthalmitis after intravitreal injection of vascular endothelial growth factor inhibitors: management and visual outcomes","volume":"125","author":"Xu","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0004","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ajo.2008.07.007","article-title":"Short-term intraocular pressure changes immediately after intravitreal injections of anti\u2013vascular endothelial growth factor agents","volume":"146","author":"Kim","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0005","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/IJG.0b013e31819c4893","article-title":"Short-term effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure","volume":"18","author":"Gismondi","year":"2009","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0006","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12886-016-0255-8","article-title":"Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab","volume":"16","author":"Lee","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70269-7","article-title":"The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis","volume":"10","author":"de Vries","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12886-018-0682-9","article-title":"Short-term effects and safety of an acute increase of intraocular pressure after intravitreal bevacizumab injection on corneal endothelial cells","volume":"18","author":"Park","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000445038","article-title":"Short-term visual acuity and intraocular pressure changes and their correlation after anti-vascular endothelial growth factor injection","volume":"236","author":"Lim","year":"2016","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0010","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/OPX.0000000000001091","article-title":"Effect of povidone iodine 5% on the cornea, vision, and subjective comfort","volume":"94","author":"Ridder","year":"2017","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0011","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.oret.2020.11.008","article-title":"Aqueous chlorhexidine compared with povidone-iodine as ocular antisepsis before intravitreal injection: a randomized clinical trial","volume":"5","author":"Ali","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0012","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/IJG.0000000000001142","article-title":"Optic nerve head perfusion before and after intravitreal antivascular growth factor injections using optical coherence tomography-based microangiography","volume":"28","author":"Wen","year":"2019","journal-title":"J Glauc"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0013","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/IJG.0000000000001894","article-title":"Intraocular pressure elevation following intravitreal anti-VEGF injections: short- and long-term considerations","volume":"30","author":"Levin","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0014","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.survophthal.2017.08.008","article-title":"The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: a review","volume":"63","author":"Bracha","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoint.2024.100001","article-title":"Assessment of intraocular pressure changes following intravitreal injections of three anti-VEGF agents","volume":"1","author":"Hibsh","year":"2024","journal-title":"AJO Int"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0016","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3928\/15428877-20090430-12","article-title":"Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections","volume":"40","author":"Kahook","year":"2009","journal-title":"Ophthal Surg Lasers Imag"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0017","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1136\/bjophthalmol-2018-312603","article-title":"Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of antivascular endothelial growth factor agents: a randomised crossover trial","volume":"103","author":"Felfeli","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0018","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5301\/ejo.5000159","article-title":"Effect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection","volume":"23","author":"El Chehab","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0019","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2147\/OPTH.S414212","article-title":"Clinical features associated with acute elevated intraocular pressure after intravitreal anti-VEGF injections","volume":"17","author":"LoBue","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0020","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bjo-2024-326053","article-title":"Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study","volume":"109","author":"Paris","year":"2025","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0021","doi-asserted-by":"crossref","DOI":"10.36351\/pjo.v39i3.1626","article-title":"Intraocular pressure elevation following intra-vitreal injection of bevacizumab, ranibizumab and triamcinolone acetonide","volume":"39","author":"Rathi","year":"2023","journal-title":"Pak J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0022","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/ICU.0000000000000036","article-title":"The link between intravitreal antivascular endothelial growth factor injections and glaucoma","volume":"25","author":"SooHoo","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0023","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/IAE.0000000000000520","article-title":"Sustained elevation of intraocular pressure after intravitreal anti-vegf agents: what is the evidence?","volume":"35","author":"Dedania","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0024","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ophtha.2018.11.019","article-title":"The effect of anti-vascular endothelial growth factor agents on intraocular pressure and glaucoma","volume":"126","author":"Hoguet","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0025","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1167\/iovs.12-9483f","article-title":"The cell and molecular biology of glaucoma: mechanisms in the conventional outflow pathway","volume":"53","author":"Stamer","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0026","first-page":"1229","article-title":"Activation of complement system in the trabecular meshwork and Schlemm\u2019s canal after anti-VEGF injections","volume":"61","author":"Wang","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12886-017-0417-3","article-title":"Acute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report","volume":"17","author":"Jeong","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0028","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00417-012-1981-0","article-title":"Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration","volume":"250","author":"Mathalone","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0029","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.oret.2023.06.003","article-title":"Accuracy, precision, and residual volume of commonly used syringes for intravitreal injections and the impact on intraocular pressure","volume":"7","author":"Agra","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/1120672119836613","article-title":"Major factors affecting intraocular pressure spike after intravitreal ranibizumab injection: vitreous reflux and its amount","volume":"29","author":"Uyar","year":"2019","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0031","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/jop.2012.0144","article-title":"Comparing the effects of three different intravitreal injection techniques on vitreous reflux and intraocular pressure","volume":"29","author":"\u00d6zkaya","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0032","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ceo.13934","article-title":"Effect of intravitreal injection speed on acute rise in intraocular pressure. The SPEED IOP study","volume":"49","author":"Salem","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0033","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00417-010-1490-y","article-title":"Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 mL bevacizumab: comparison between 27-gauge and 30-gauge needle","volume":"248","author":"Lorenz","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0034","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/bjophthalmol-2015-307595","article-title":"Changes in intraocular pressure in study and fellow eyes in the IVAN trial","volume":"100","author":"Foss","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0035","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bjo.2010.180729","article-title":"Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents","volume":"95","author":"Good","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0036","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s00417-019-04431-x","article-title":"Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection","volume":"257","author":"Lam","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0037","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1055\/s-0029-1245201","article-title":"Effect of brimonidine\/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab","volume":"227","author":"Theoulakis","year":"2010","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0038","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40942-023-00517-1","article-title":"Can intravitreal injections with higher volume cause higher intraocular eye pressure? Considerations for anti-complement injections in normal and glaucomatous eyes","volume":"9","author":"Meyer","year":"2023","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0039","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jcjo.2022.06.002","article-title":"Comparison of intraocular pressure measured by iCare tonometers and Goldmann applanation tonometer","volume":"58","author":"Sachdeva","year":"2023","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40662-021-00249-z","article-title":"Evaluation of rebound tonometer iCare IC200 as compared with IcarePRO and Goldmann applanation tonometer in patients with glaucoma","volume":"8","author":"Nakakura","year":"2021","journal-title":"Eye Vis"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0041","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jaapos.2021.07.010","article-title":"Rebound tonometry by iCare 200 (IC200): comparison with Tono-Pen in the operating room and Goldmann applanation in the clinic","volume":"25","author":"Umfress","year":"2021","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.jcjo.2025.09.005_bib0042","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ogla.2020.08.004","article-title":"Agreement of intraocular pressure measurement of Icare IC200 with Goldmann applanation tonometer in adult eyes with normal cornea","volume":"4","author":"Badakere","year":"2021","journal-title":"Ophthalmol Glaucoma"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418225003783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418225003783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:49:06Z","timestamp":1775695746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418225003783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0008418225003783"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.09.005","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transient vision and intraocular pressure changes following anti-vascular endothelial growth factor injection","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Canadian Ophthalmological Society.","name":"copyright","label":"Copyright"}]}}